B cells in the tumor microenvironment: Multi-faceted organizers,regulators, and effectors of anti-tumor immunity |
| |
| Affiliation: | 1. Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada;2. Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada;3. Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 3E6, Canada;1. myNEO NV, 9000 Ghent, Belgium;2. Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium;3. Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium;4. Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium;5. Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium;6. Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA;7. Department of Data Analysis and Mathematical Modelling, Ghent University, Ghent, Belgium;8. Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands;9. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA;1. Department of Pathology, Stanford University, Stanford, CA, USA;2. Immunology Program, Stanford University, Stanford, CA, USA;3. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;4. Weill Cornell Medical College, New York, NY, USA;5. Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA;6. Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;7. Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY, USA;8. Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA;9. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;10. Cancer Biology Program, Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA;11. Precision Pathology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA;12. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;13. Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, USA;14. Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA;15. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA;16. Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA;17. Stanford Cancer Institute, Stanford University, Stanford, CA, USA;18. Parker Institute for Cancer Immunotherapy, Stanford University, Stanford, CA, USA;19. Santa Ana Bio, Alameda, CA, USA;1. Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA;2. Department of Ophthalmology, Yale University School of Medicine, New Haven, CT, USA;3. Department of Genetics, Yale University School of Medicine, New Haven, CT, USA;1. Program in Immunology, Stanford University, Stanford, CA 94305, USA;2. Department of Pathology, Stanford University, Stanford, CA 94305, USA;3. Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA;1. Institute of Oncology Research (IOR), 6500 Bellinzona, Switzerland;2. Università della Svizzera Italiana, Faculty of Biomedical Sciences, 6900 Lugano, Switzerland;3. The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK;4. Institute for Research in Biomedicine (IRB), 6500 Bellinzona, Switzerland;5. Institute of Oncology of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland;6. Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy;7. Veneto Institute of Molecular Medicine, Padova, Italy;8. Department of Urology, Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano - Civico USI - Università della Svizzera Italiana, Lugano, Switzerland;9. Computational Oncology Unit, Department of Oncology, IRCCS Istituto di Ricerche Farmacologiche ‘Mario Negri’, Via Mario Negri 2, 20156 Milano, Italy;10. Department of Medicine, University of Padova, Padova, Italy;11. Department of Health Sciences and Technology (D-HEST) ETH Zurich, 8093 Zurich, Switzerland;1. Department of Surgery, University of Michigan, Ann Arbor, MI, USA;2. Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA;3. Department of Pathology, University of Michigan, Ann Arbor, MI, USA;4. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA;5. Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA;6. Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA;7. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA;8. Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA;9. Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA;10. Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA;11. Graduate Program in Immunology, University of Michigan, Ann Arbor, MI, USA;12. Graduate Program in Cancer Biology, University of Michigan, Ann Arbor, MI, USA |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
